Forte Biosciences, Inc. (FBRX)
- Previous Close
0.7386 - Open
0.7200 - Bid --
- Ask --
- Day's Range
0.7100 - 0.7385 - 52 Week Range
0.3800 - 1.1500 - Volume
14,197 - Avg. Volume
35,014 - Market Cap (intraday)
26.201M - Beta (5Y Monthly) 1.65
- PE Ratio (TTM)
-- - EPS (TTM)
-1.0000 - Earnings Date May 13, 2024 - May 17, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
2.88
Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
www.fortebiorx.comRecent News: FBRX
Performance Overview: FBRX
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FBRX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FBRX
Valuation Measures
Market Cap
26.91M
Enterprise Value
-10.22M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.76
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
0.31
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-50.15%
Return on Equity (ttm)
-84.92%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-31.48M
Diluted EPS (ttm)
-1.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
37.12M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-17.4M